Results 231 to 240 of about 1,206,149 (284)
Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann +61 more
wiley +1 more source
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
LRP4-Related Lethal Syndromic Form of Syndactyly in Limousin Cattle. [PDF]
Jacinto J +5 more
europepmc +1 more source
Reply to Bousdar et al.: Common inherited loss-of-function mutations in the innate sensor <i>NOD2</i> contribute to exceptional immune response to cancer immunotherapy. [PDF]
Barnet MB, Jackson KJL, Goodnow CC.
europepmc +1 more source
Dual molecular diagnosis of CEP290 and GLI3 mutations identified in an infant with leber congenital amaurosis and postaxial polydactyly, a Bardet-Biedl syndrome phenocopy. [PDF]
Wang L +6 more
europepmc +1 more source
A novel genetic strategy to interrogate an unknown phenotypic modifier: Sdhc KO-Robertsonian mice develop frequent thyroid abnormalities with papillary thyroid carcinoma-like features. [PDF]
Bayley JP, Rebel HG, Devilee P.
europepmc +1 more source

